We improve the quality of life by creating new medicines

RUS | ENG

+7 (495) 925-30-74

About us
Manufacturing
- API & FDF Experimental Producton
- Biotechnological Producton (BioIntegrator)
Portfolio
Business Incubator
News
Contacts

+7 (495) 925-30-74

About us
Manufacturing
- API & FDF Experimental Producton
- Biotechnological Producton (BioIntegrator)
Portfolio
Business Incubator
News
Contacts

+7 (495) 925-30-74

Home >> Мероприятия

Мероприятия

CONTENTS

COMPANY NEWS

24.03.2021 Avifavir obtains its first registration in Asia

10.03.2021 Chromis published results of a multi-center open label post-marketing clinical study in 940 COVID-19 patients confirming efficacy of Avifavir at CROI2021

20.11.2020 The international expert community highlights the efficacy and safety of Avifavir in COVID-19 treatment

09.11.2020 Avifavir will be made available to outpatients free of charge for the treatment of COVID-19

24.09.2020 RDIF and ChemRar to supply Avifavir to 17 countries

all news

Copyright © 2021 HTC "Chemrar"